Skip to main content

Drug–Drug Interactions Still High in the Medical ICU


June 11, 2012 — Drug–drug interactions (DDIs) are frequent occurrences in the medical intensive care unit (MICU). The severity of the condition and the drug combinations used in the MICU are distinct from those of the DDIs published in other ICU settings (eg, cardiac ICU). Prevention of these DDIs is an important aspect of patient safety.
Pamela L. Smithburger, PharmD, from the Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pennsylvania, and colleagues presented the results of a 4-week, prospective, observational study in an article published online June 7 in the International Journal of Pharmacy Practice. This is the first study that evaluates drug interactions specifically in a MICU population with a variety of diagnoses and comorbid disease states. The authors conclude with the suggestion that patient characteristics and location should be considered when developing a DDI alerting system.
The study included 240 patient evaluations. Two interaction databases (Micromedex and Lexi-Interact) were used to identify DDIs and assign a severity rating to the identified DDIs. Of 457 DDIs identified, roughly 25% (114/457) were considered to be major interactions per at least 1 of the databases used. The rate of DDIs was 190.4/100 patients, and the most commonly involved medications were antihypertensive and anticoagulant/antiplatelet agents.
In accordance with requirements of the institutional review board and the health insurance portability and accountability act, the study did not collect patient identifiers, meaning that clinical outcomes could not be followed over time. Other limitations included lack of generalizability; the academic institution where the evaluation took place had particularly ill MICU patients as a result of transfers from community hospitals and also housed many posttransplant patients.
The authors identified 3 possible reasons for overlooking DDIs in the presence of an alerting system: pharmacist alert fatigue, judgment of an appropriate risk–benefit ratio for the patient receiving the interacting drugs, or clinical decision support software (CDSS) that did not include the DDIs identified by the drug interaction databases used in this study. The authors emphasize that use of computerized physician order entry and CDSS in the ICU setting should provide practitioners with a way to use technology at the point of order entry.
The authors also note that studies in cardiac ICUs have identified more DDIs per 100 patient days than were identified in this study. Moreover, a previously published study conducted in a mixed ICU found that 70% of patients had a DDI during the study period.
Altogether, these studies underscore the fact that drug interaction compendia need to be improved to better identify and guide clinical decision-making.
The authors have disclosed no relevant financial relationships.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...
Post a Comment
Read more

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...
Post a Comment
Read more